Doyle C, Lohmann AE, Iqbal N, Henning JW, et al. A Canadian real-world, multi-center, prospective, observational study assessing the treatment duration, the treatment sequence, and the overall survival for patients treated with endocrine therapy +/- targeted therapy in HR + HER2-negative advanced br Breast Cancer Res Treat 2025 Jan 23. doi: 10.1007/s10549-024-07580.
PMID: 39847203